Clinical Trial Update: CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

View source ↗

Summary

A clinical trial evaluating CSF protein markers as predictors of response to CSF shunt in normal pressure hydrocephalus. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Pressure Hydrocephalus

Snippet

Sponsor: University of Valencia | Conditions: Beta-amiloid and Phospho-tau Proteins in CSF, Ventricular Size After CSF Shunt | Status: RECRUITING